Microscopic and macroscopic models for the onset and progression of Alzheimer's disease

In the first part of this paper we review a mathematical model for the onset and progression of Alzheimer's disease (AD) that was developed in subsequent steps over several years. The model is meant to describe the evolution of AD in vivo. In [Y. Achdou et al., 2013] we treated the problem at a microscopic scale, where the typical length scale is a multiple of the size of the soma of a single neuron. Subsequently, in [M. Bertsch at al., 2016] we concentrated on the macroscopic scale, where brain neurons are regarded as a continuous medium, structured by their degree of malfunctioning. In the second part of the paper we consider the relation between the microscopic and the macroscopic models. In particular we show under which assumptions the kinetic transport equation, which in the macroscopic model governs the evolution of the probability measure for the degree of malfunctioning of neurons, can be derived from a particle-based setting. In the microscopic model we consider basically mechanism i), modelling it by a system of Smoluchowski equations for the amyloid concentration (describing the agglomeration phenomenon), with the addition of a diffusion term as well as of a source term on the neuronal membrane. At the macroscopic level instead we model processes i) and ii) by a system of Smoluchowski equations for the amyloid concentration, coupled to a kinetic-type transport equation for the distribution function of the degree of malfunctioning of the neurons. The second equation contains an integral term describing the random onset of the disease as a jump process localized in particularly sensitive areas of the brain. Even though we deliberately neglected many aspects of the complexity of the brain and the disease, numerical simulations are in both cases (microscopic and macroscopic) in good qualitative agreement with clinical data.

[1]  M. Smoluchowski Versuch einer mathematischen Theorie der Koagulationskinetik kolloider Lösungen , 1918 .

[2]  T. L. Hill Length dependence of rate constants for end-to-end association and dissociation of equilibrium linear aggregates. , 1983, Biophysical journal.

[3]  R. Murphy,et al.  Kinetics of aggregation of synthetic beta-amyloid peptide. , 1992, Archives of biochemistry and biophysics.

[4]  Regina M. Murphy,et al.  Kinetics of aggregation of synthetic β-amyloid peptide , 1992 .

[5]  T. Good,et al.  Effect of beta-amyloid block of the fast-inactivating K+ channel on intracellular Ca2+ and excitability in a modeled neuron. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[6]  M McNamara,et al.  Aggregation and disaggregation of senile plaques in Alzheimer disease. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[7]  G. Goodhill Diffusion in Axon Guidance , 1997, The European journal of neuroscience.

[8]  W. Griffin,et al.  Glial‐Neuronal Interactions in Alzheimer's Disease: The Potential Role of a ‘Cytokine Cycle’ in Disease Progression , 1998, Brain pathology.

[9]  C. Nicholson,et al.  Extracellular space structure revealed by diffusion analysis , 1998, Trends in Neurosciences.

[10]  B Urbanc,et al.  Dynamics of plaque formation in Alzheimer's disease. , 1999, Biophysical journal.

[11]  Regina M. Murphy,et al.  Probing the Kinetics of β-Amyloid Self-Association , 2000 .

[12]  L. Edelstein-Keshet,et al.  Exploring the formation of Alzheimer's disease senile plaques in silico. , 2002, Journal of theoretical biology.

[13]  M. Meyer-Lühmann Experimental approaches to study cerebral amyloidosis in a transgenic mouse model of Alzheimer's disease , 2004 .

[14]  M. Mattson Erratum: Pathways towards and away from Alzheimer's disease (Nature (2004) 430 (631-639)) , 2004 .

[15]  Vladimir I. Clue Harmonic analysis , 2004, 2004 IEEE Electro/Information Technology Conference.

[16]  M. Mattson Pathways towards and away from Alzheimer's disease , 2004, Nature.

[17]  Henrik Zetterberg,et al.  Plasma Aβ in Alzheimer's disease—up or down? , 2006, The Lancet Neurology.

[18]  G. Toscani,et al.  Kinetic models of opinion formation , 2006 .

[19]  D. Selkoe,et al.  Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide , 2007, Nature Reviews Molecular Cell Biology.

[20]  D. Selkoe,et al.  Aβ Oligomers – a decade of discovery , 2007, Journal of neurochemistry.

[21]  Agneta Nordberg,et al.  Amyloid imaging in Alzheimer's disease , 2007, Neuropsychologia.

[22]  D. Holtzman,et al.  Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s disease , 2008, Nature.

[23]  C. Jack,et al.  Mild cognitive impairment: ten years later. , 2009, Archives of neurology.

[24]  S. de Santi,et al.  Pre-clinical detection of Alzheimer's disease using FDG-PET, with or without amyloid imaging. , 2010, Journal of Alzheimer's disease : JAD.

[25]  D. Teplow,et al.  Structure-neurotoxicity relationships of amyloid β-protein oligomers , 2009, Neuroscience Research.

[26]  B. Strooper,et al.  The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics , 2011, Nature Reviews Drug Discovery.

[27]  H. Braak,et al.  Alzheimer’s pathogenesis: is there neuron-to-neuron propagation? , 2011, Acta Neuropathologica.

[28]  M. Weiner,et al.  A Network Diffusion Model of Disease Progression in Dementia , 2012, Neuron.

[29]  G. E. Vates,et al.  A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid β , 2012, Science Translational Medicine.

[30]  Eric M Reiman,et al.  Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study , 2012, The Lancet Neurology.

[31]  J. Sérot,et al.  A possible role for CSF turnover and choroid plexus in the pathogenesis of late onset Alzheimer's disease. , 2012, Journal of Alzheimer's disease : JAD.

[32]  R. Mayeux,et al.  Epidemiology of Alzheimer disease. , 2012, Cold Spring Harbor perspectives in medicine.

[33]  Paco Martorell,et al.  Monetary costs of dementia in the United States. , 2013, The New England journal of medicine.

[34]  Yves Achdou,et al.  A qualitative model for aggregation and diffusion of $$\beta $$-amyloid in Alzheimer’s disease , 2013, Journal of mathematical biology.

[35]  Laurent Pujo-Menjouet,et al.  Alzheimer’s disease: analysis of a mathematical model incorporating the role of prions , 2013, Journal of mathematical biology.

[36]  M. C. Tesi,et al.  A QUALITATIVE MODEL FOR AGGREGATION-FRAGMENTATION AND DIFFUSION OF β-AMYLOID IN ALZHEIMER’S DISEASE , 2014 .

[37]  Lorenzo Pareschi,et al.  Reviews , 2014 .

[38]  N. Bobkova,et al.  Beta-Amyloid and Tau-Protein: Structure, Interaction, and Prion-Like Properties , 2015, Biochemistry (Moscow).

[39]  Bruno Franchi,et al.  From a Microscopic to a Macroscopic Model for Alzheimer Disease: Two-Scale Homogenization of the Smoluchowski Equation in Perforated Domains , 2016, J. Nonlinear Sci..

[40]  Avner Friedman,et al.  Mathematical model on Alzheimer’s disease , 2016, BMC Systems Biology.

[41]  Andrea Tosin,et al.  Alzheimer's disease: a mathematical model for onset and progression. , 2015, Mathematical medicine and biology : a journal of the IMA.

[42]  B. Franchi,et al.  Smoluchowski Equation with Variable Coefficients in Perforated Domains: Homogenization and Applications to Mathematical Models in Medicine , 2017 .